Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

February 1, 2018

Conditions
Colorectal Cancer
Interventions
DRUG

FOLFOXIRI

"Treatment of FOLFOXIRI regimen at first line with dosage:~Irinotecan: 165 mg / m2, intravenous infusion for 1 hour. Day 1, 15. Oxaliplatin: 85 mg / m2, intravenously for 2 hours Day 1, 15 Calcium folinate 200 mg / m2, intravenously for 2 hours Day 1, 15 5FU 3200 mg / m 2, intravenous infusion continuously for 48 hours Day 1, 2, 3, 15, 16, 17 Every 4 weeks. Each cycle has 2 infusion times, the first one is the first day, the second one is the 15th day"

Trial Locations (1)

10000

Hanoi Medical University, Hanoi

All Listed Sponsors
lead

Hanoi Medical University

OTHER

NCT03504618 - Research on the Treatment of Metastatic Colon Cancer Patients Treated by FOLFOXIRI | Biotech Hunter | Biotech Hunter